Monday, 28 September 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Cohance Lifesciences Ltd

NSE: COHANCE · BSE: 543064 · Pharmaceuticals & Biotechnology · 10 announcements

Share price
₹459.25
Market cap
₹17,571 Cr
Revenue (annual)
₹2,269 Cr
Net profit (annual)
₹179.2 Cr
P/E (TTM)
165.4×Sector 50.4×
Promoter holding
57.49%+0.00% QoQ
FII holding
6.50%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

Time

1 announcement with these filters

11:37 IST BSE
Business Update

Cohance Lifesciences Business Update

Cohance Lifesciences completed a USFDA inspection at its Jaggaiahpet API facility, receiving a Form 483 with five observations. The company has initiated corrective and preventive actions.